TOC - Pharmaceutical Continuous Manufacturing Market Size

Pharmaceutical Continuous Manufacturing Market Report by Therapeutics Type (Large Molecules, Small Molecules), Formulation (Solid Formulation, Liquid and Semi-solid Formulation), Application (Final Drug Product Manufacturing, API Manufacturing), End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A5935

Buy Now

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Pharmaceutical Continuous Manufacturing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Therapeutics Type
    6.1    Large Molecules
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Small Molecules
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Formulation
    7.1    Solid Formulation
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Liquid and Semi-solid Formulation
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Application
    8.1    Final Drug Product Manufacturing
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    API Manufacturing
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by End User
    9.1    Pharmaceutical Companies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Contract Manufacturing Organizations
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10 Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11 SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Baker Perkins
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
        15.3.2    Coperion GmbH (Hillenbrand Inc.)
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Eli Lilly and Company
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    GEA Group Aktiengesellschaft
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Glatt GmbH
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Korsch AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Novartis AG
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Siemens
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    SK biotek
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
        15.3.10    Thermo Fisher Scientific Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Viatris Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials

List of Figures

Figure 1: Global: Pharmaceutical Continuous Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Therapeutics Type (in %), 2024
Figure 5: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Formulation (in %), 2024
Figure 6: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Application (in %), 2024
Figure 7: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by End User (in %), 2024
Figure 8: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Region (in %), 2024
Figure 9: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Pharmaceutical Continuous Manufacturing (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Pharmaceutical Continuous Manufacturing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: North America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: North America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: United States: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: United States: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Canada: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Canada: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: China: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: China: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Japan: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Japan: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: India: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: India: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: South Korea: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: South Korea: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Australia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Australia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Indonesia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Indonesia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Europe: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Europe: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Germany: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Germany: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: France: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: France: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: United Kingdom: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: United Kingdom: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Italy: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Italy: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Spain: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Spain: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Russia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Russia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Latin America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Latin America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Brazil: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Brazil: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Mexico: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Mexico: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Breakup by Country (in %), 2024
Figure 75: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Global: Pharmaceutical Continuous Manufacturing Industry: SWOT Analysis
Figure 77: Global: Pharmaceutical Continuous Manufacturing Industry: Value Chain Analysis
Figure 78: Global: Pharmaceutical Continuous Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pharmaceutical Continuous Manufacturing Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Therapeutics Type (in Million USD), 2025-2033
Table 3: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Formulation (in Million USD), 2025-2033
Table 4: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Pharmaceutical Continuous Manufacturing Market: Competitive Structure
Table 8: Global: Pharmaceutical Continuous Manufacturing Market: Key Players

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.